A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2002
10/10/2002	WO2002079195A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/10/2002	WO2002079193A1 Inhibitors of cyclin dependent kinases as anti-cancer agent
10/10/2002	WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002	WO2002079183A1 Halogenated rhodamine derivatives and applications thereof
10/10/2002	WO2002079170A2 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
10/10/2002	WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079167A1 Geldanamycin derivative and method of treating cancer using same
10/10/2002	WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079147A2 Inhibitors of prenyl-protein transferase
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002079139A1 Conjugated unsaturated glyceride mixtures and a method for producing the same
10/10/2002	WO2002078766A2 Combination therapy
10/10/2002	WO2002078739A1 Drugs containing genetically modified antibody against ganglioside gd3
10/10/2002	WO2002078733A1 Monocyte-specific particulate delivery vehicle
10/10/2002	WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain
10/10/2002	WO2002078722A1 An antineoplastic drug
10/10/2002	WO2002078720A2 Antibiotics from bacteria isolated from amphibian skin
10/10/2002	WO2002078719A1 Antitumor methods and compositions comprising sesquiterpene derivatives
10/10/2002	WO2002078718A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002	WO2002078716A2 Methylated promoters for intraductal treatment of breast cancer
10/10/2002	WO2002078705A1 Hsp inductor
10/10/2002	WO2002078704A1 Use of cyclopamine in the treatment of psoriasis
10/10/2002	WO2002078703A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
10/10/2002	WO2002078699A1 Compounds and methods
10/10/2002	WO2002078698A2 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
10/10/2002	WO2002078697A1 Compounds and methods
10/10/2002	WO2002078696A1 Compounds and methods
10/10/2002	WO2002078694A1 Photosensitiser and method for production thereof
10/10/2002	WO2002078683A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002	WO2002078682A2 Estrogen replacement therapy
10/10/2002	WO2002078680A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002	WO2002078678A2 Methods of treating cancer using cyplastin combined with a dioxolane nucleoside such as troxacitabine
10/10/2002	WO2002078642A2 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer
10/10/2002	WO2002078639A2 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002	WO2002078638A2 Morpholino imaging and therapy
10/10/2002	WO2002078636A2 Detection and treatment of colorectal cancer
10/10/2002	WO2002078620A2 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
10/10/2002	WO2002078619A2 Alkynylated single-strand oligonucleotide and uses thereof
10/10/2002	WO2002078617A2 Materials and methods for treatment of cancer and identification of anti-cancer compounds
10/10/2002	WO2002078614A2 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
10/10/2002	WO2002078613A2 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response
10/10/2002	WO2002078609A2 Immunoglobulin construct containing tumor specific p53bp2 sequences for eliciting an anti-tumor response
10/10/2002	WO2002078607A2 Mucin peptide with immunoenhancing properties
10/10/2002	WO2002078599A2 CD8α + LYMPHOID DENDRITIC CELL DIFFERENTIATED FROM HUMAN HEMATOPOIETIC STEM CELL AND A METHOD FOR DIFFERENTIATION
10/10/2002	WO2002078598A2 Peptides and antibodies to muc 1 proteins
10/10/2002	WO2002078526A2 Cancer-testis antigens
10/10/2002	WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
10/10/2002	WO2002058738A3 Use of rad51 inhibitors for p53 gene therapy
10/10/2002	WO2002058636A3 Novel cannabimimetic ligands
10/10/2002	WO2002051390A3 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
10/10/2002	WO2002051386A3 Lipid microparticles by cryogenic micronization
10/10/2002	WO2002043776A3 Neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer
10/10/2002	WO2002042318A3 Transcobalamin receptor binding conjugates for neutron capture therapy
10/10/2002	WO2002039952A3 Synergistic ecta compositions
10/10/2002	WO2002032450A3 Vaccines
10/10/2002	WO2002024706A3 Water soluble rapamycin esters
10/10/2002	WO2002016419A3 Progression suppressed gene 13 (psgen 13) and uses thereof
10/10/2002	WO2002015915A3 Method for inducing an anti-tumor and anti-cachexia immune response in mammals
10/10/2002	WO2002010766A3 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
10/10/2002	WO2002007739A3 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma
10/10/2002	WO2002004612A3 Drug metabolizing enzymes
10/10/2002	WO2001098353A3 Secreted proteins
10/10/2002	WO2001095929A3 Interferon for treatment of multiple sclerosis
10/10/2002	WO2001077174A3 Human transporters and ion channels
10/10/2002	WO2001074382A9 Method of treatment using ligand-immunogen conjugates
10/10/2002	WO2001072728A9 Novel piperazine derivatives
10/10/2002	WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002	US20020147997 Animal model for use in the diagnosis, prevention and treatment of cancer
10/10/2002	US20020147346 New crystal modification of torasemide
10/10/2002	US20020147343 Cell antiproliferative agents; anticancer agents
10/10/2002	US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002	US20020147339 5-cyano-2-aminopyrimidine derivatives
10/10/2002	US20020147332 Novel nucleoside and oligonucleotide analogues
10/10/2002	US20020147304 Non-naturally occurring lipoprotein particle
10/10/2002	US20020147238 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen
10/10/2002	US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002	US20020147214 Enzyme inhibitors; anticancer agents
10/10/2002	US20020147213 Side effect reduction; synergistic mixture
10/10/2002	US20020147205 Heterocyclic compounds
10/10/2002	US20020147203 Tyrosine kinase inhibitors
10/10/2002	US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002	US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002	US20020147188 Protease inhibitors
10/10/2002	US20020147187 Antiproliferative agents; anticancer agents
10/10/2002	US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same
10/10/2002	US20020147175 Antiproliferative agents; anticancer agents; enzyme catalyzed therapy activation
10/10/2002	US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
10/10/2002	US20020147161 Novel antisense inhibition of rad51
10/10/2002	US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002	US20020147138 Anticancer agents
10/10/2002	US20020147136 Tetrapeptide
10/10/2002	US20020146846 Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
10/10/2002	US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002	US20020146830 Methods and compositions for delivery of pharmaceutical agents
10/10/2002	US20020146819 Human TSLP DNA and polypeptides
10/10/2002	US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002	US20020146770 RAS proteins
10/10/2002	US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002	US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002	US20020146750 Mucin for use in the diagnosiss and treatment of cancer

1 ... 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 ... 2211